Valuation: Hayat Pharmaceutical Industries Co. PLC

Market Cap 30.88M 43.57M 38.32M 35.6M 32.74M 61.4M 4.22B 62.5M 426M 166M 2.06B 164M 160M 7.14B P/E 2024
7.53x
P/E 2025 13.6x
Enterprise Value 24.79M 34.99M 30.77M 28.59M 26.29M 49.31M 3.39B 50.19M 342M 133M 1.65B 131M 129M 5.73B EV / Sales 2024
1.08x
EV / Sales 2025 1.48x
Free-Float
14.49%
Yield 2024
8.98%
Yield 2025 5.76%
1 day+1.56%
1 week+1.56%
Current month+3.83%
1 month+4.17%
3 months-1.52%
6 months-1.22%
Current year-1.52%
1 week 3.12
Extreme 3.12
3.25
1 month 3.11
Extreme 3.11
3.25
Current year 3.1
Extreme 3.1
3.55
1 year 2.9
Extreme 2.9
3.55
3 years 2.4
Extreme 2.4
3.55
5 years 2.4
Extreme 2.4
4.33
10 years 1.72
Extreme 1.72
4.33
Manager TitleAgeSince
Chief Executive Officer 68 2010-02-07
Director TitleAgeSince
Chairman 68 2002-02-16
Director/Board Member 71 2009-11-26
Director/Board Member 78 2010-02-07
Change 5-day change 1-year change 3-year change Capi.($)
+1.56%+1.56%+6.21%+8.33% 43.57M
+1.97%+1.43%+48.44%+156.66% 1,057B
+1.42%+3.72%+53.32%+52.34% 624B
+1.43%+0.99%+34.83%+78.74% 454B
+0.14%+4.88%+32.21%+28.15% 341B
-1.07%+1.23%+35.29%+39.36% 297B
-0.82%+0.14%+15.64%+16.99% 262B
-0.49%-3.21%-28.58%-41.95% 215B
+1.49%-0.02%+20.14%+58.21% 201B
+0.40%-3.99%+15.23%+62.28% 162B
Average -0.05%+1.11%+23.28%+45.91% 361.4B
Weighted average by Cap. -0.53%+1.57%+34.93%+75.42%

Financials

2024 2025
Net sales 16.71M 23.58M 20.74M 19.27M 17.72M 33.23M 2.28B 33.83M 230M 89.86M 1.11B 88.52M 86.61M 3.86B 17.11M 24.14M 21.23M 19.73M 18.14M 34.02M 2.34B 34.63M 236M 92.01M 1.14B 90.64M 88.68M 3.96B
Net income 3.09M 4.36M 3.83M 3.56M 3.28M 6.14M 422M 6.25M 42.6M 16.62M 206M 16.37M 16.01M 714M 2.31M 3.26M 2.86M 2.66M 2.45M 4.59M 315M 4.67M 31.82M 12.41M 154M 12.23M 11.96M 534M
Net Debt -5.22M -7.37M -6.48M -6.02M -5.54M -10.38M -713M -10.57M -71.97M -28.07M -348M -27.65M -27.06M -1.21B -6.08M -8.58M -7.55M -7.01M -6.45M -12.09M -831M -12.31M -83.85M -32.7M -405M -32.22M -31.52M -1.41B
Logo Hayat Pharmaceutical Industries Co. PLC
Hayat Pharmaceutical Industries Company PSC is a Jordan-based company engaged in the pharmaceutical sector. The Company specializes in the manufacture of different forms of human pharmaceuticals, veterinary medicines, medical plasters, medical gauze and medical braces, in addition to the production of skin care and beauty supplies and surgical suture. The Company’s manufacturing facility is spread over an approximately 8,000 square meter area on the outskirts of the capital city Amman. The Company’s production areas are divided into the following: Solid production area, which covers tablets, capsules, dry suspension, suppositories, syrups and solutions, cream and ointments, and Semi-solid and Liquid production area, which includes creams, ointments, gels and emulsions, suppositories line, syrups line and shampoo line. The Company’s products include Anti-microbials, Gynecological, Dermatological, Gastrointestinal, Antihypertensives and Vasoactive, Neurological, and Respiratory products.
Employees
246
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. HPIC Stock